CJC 1295 No DAC Australia: Buy Mod GRF 1-29 Online

Shop CJC-1295 No DAC as a 10 mg Vial With Full Lot Data

Order the short-acting member of the CJC-1295 family, the stabilised GHRH core without the arm that binds it to albumin. It is the analogue to choose for brief, repeatable growth hormone pulses, and the 10 mg vial carries twice the fill of our DAC version.

What Is CJC 1295 No DAC?

CJC-1295 No DAC is a lab-built version of the active front section of growth hormone releasing hormone, rebuilt with four amino acid swaps so it lasts long enough to study. Researchers also call it Mod GRF 1-29. It switches on the GHRH receptor, the same switch the hypothalamus uses to tell the pituitary when to release growth hormone.

Why each of the four swaps is there

Every substitution repairs a specific weak point in the natural sequence, and knowing which one does what helps when reading a certificate or an older paper.

• Position 2, D-alanine: a mirror-image residue that the enzyme DPP-4 cannot clip, so the chain keeps its first two residues.
• Position 8, glutamine instead of asparagine: asparagine slowly deamidates in water, changing the charge and the mass of the peptide.
• Position 15, alanine instead of glycine: alanine favours the helical shape the receptor recognises.
• Position 27, leucine instead of methionine: methionine oxidises easily, and leucine is a near match in size that does not.

How the GHRH pathway works

In the body, neurons in the arcuate nucleus release GHRH into the small portal vessels that feed the anterior pituitary. There it binds a class B G protein coupled receptor on somatotroph cells. The receptor couples to Gs, cyclic AMP climbs, and protein kinase A drives both the release of stored growth hormone and the transcription of new hormone. Somatostatin pushes the other way through Gi, which is why the pulse pattern of growth hormone reflects a running contest between the two signals. The importance of this receptor shows up clearly in the little mouse, a dwarf strain whose phenotype traces to a single amino acid change in the GHRH receptor.

Here is the honest gap in the literature. Very little published work tests the CJC 1295 no DAC molecule by itself. Most clinical data on the CJC name come from the albumin-bound conjugate, and most of the short-acting human data come from sermorelin, the unmodified fragment. Mod GRF sits between the two, and a design that relies on it should say so plainly in its methods.

Our practical tip: in pituitary cell work, measure cyclic AMP as well as secreted growth hormone. The cAMP signal appears within minutes, gives a cleaner concentration curve, and with forskolin as a positive control it tells you whether a weak result is the receptor or the cells. How it differs from the long-acting sibling is laid out in the complete DAC and No DAC comparison.

Buy CJC 1295 No DAC Online as the Stabilised GRF 1-29

Human GHRH, isolated in 1982, has 44 amino acids, but its first 29 residues are enough to activate the receptor, and that fragment, GRF 1-29, became sermorelin. It is cleaved within minutes by dipeptidyl peptidase-4. Modified GRF (1-29) fixes that weakness with four substitutions, and the CJC name came from ConjuChem, the Canadian company that later attached a drug affinity complex to make the long-acting version.

Buy the 29-residue amidated chain here without that complex. It is a research reagent, not a registered medicine, and is sold only for laboratory work. Labs choose it over native sermorelin when they need the same receptor target with enough stability to survive a full sampling window in culture medium or plasma. Related analogues and secretagogues are grouped in our growth hormone peptides range.

Where CJC 1295 No DAC Sits Under Australian Rules

Each unit is a single vial of 10 mg Mod GRF (1-29) dried to a white cake, with No DAC printed on the label so it cannot be confused with the 5 mg albumin-binding sibling. Nothing is premixed and no second peptide shares the glass. The tetrasubstituted chain is essentially ConjuChem's CJC-1295 minus the extra C-terminal lysine that carries the albumin-reactive maleimide group. It was never developed into a medicine in its own right, so the name CJC-1295 No DAC is a market label borrowed from the conjugated molecule.

Is CJC 1295 legal in Australia?

Here the naming gets interesting. The Poisons Standard entry that reads "CJC-1295" carries CAS 863288-34-0, which is the DAC version, so on a strict reading it does not describe this molecule. That changes little in practice. As of October 2026, the June 2026 Poisons Standard places growth hormone releasing hormones (GHRHs) as a class in Schedule 4, prescription only, and in Appendix D, clause 5, where possession without authority is illegal, and Mod GRF (1-29) is a GHRH analogue by any definition. No product containing it is on the ARTG, while its unmodified parent fragment, sermorelin, is named separately in Schedule 4.

Anti-doping lists take the same broad view. WADA's 2026 list groups CJC-1295, sermorelin and tesamorelin together as GHRH analogues under S2, prohibited at all times, and that list binds athletes tested by Sport Integrity Australia.

AminoBlend keeps CJC-1295 No DAC for sale in Australian stock purely as a research reagent: buyers must be 18 or older, and the vial is not for human or veterinary use. Anyone weighing the No DAC form against the conjugate should also read our CJC-1295 and ipamorelin safety research guide, which gathers what the human trials recorded.

Order CJC-1295 No DAC in 10 mg Vials From One Lot

Shop the single fill, a 10 mg vial at $79, or $7.90 per mg. Because the synthesis skips the DAC conjugation step, we can offer double the peptide of the 5 mg DAC vial at the same price, which suits pulsatile designs that use material faster than sustained-release work.

Order a full study series at once, so every vial shares a lot and one certificate. Pairing studies usually add ipamorelin to the same cart. The peptide is released only to adult buyers, aged 18 or more, who tick the research-use declaration before paying.

Shop CJC 1295 No DAC With Structure and Purity on File

You will not find a CAS number on this page. The figure that often circulates for this molecule, 863288-34-0, belongs to the DAC version, and we would rather leave the row out than print a wrong value. Identity is confirmed instead by mass, near 3367.9 g/mol, and by the sequence on the certificate.

That mass line matters more than usual, because many vials on the market are labelled only CJC-1295 and the two forms look identical as powders. A reading near 3647 would indicate DAC material, and a value in between would suggest a truncated or incompletely deprotected chain worth questioning before use. Buy only once HPLC purity checks out on the same report, filed by lot in our COA library. Any lab weighing up the best CJC 1295 peptide should start with exactly that mass line.

Order CJC-1295 No DAC Online and Store the Vial

A local reseller is unnecessary, because this online store supplies laboratories across Australia from one domestic stock and sends out every order received before the 3pm weekday cut-off on the same day. Follow the parcel on the order tracking page once it leaves.

Buy bacteriostatic water with your vial. Let the vial reach room temperature, trickle the diluent down the glass and rotate it gently until clear, without shaking. Two millilitres added to the 10 mg vial produce a 5 mg/mL solution, and the general peptide calculator converts any other volume.

Mod GRF (1-29) is more fragile in solution than dry, and its DPP-4 protection does nothing against slow hydrolysis in water, so keep sealed vials at -20 °C and the prepared solution at 2 to 8 °C in aliquots, using each portion without delay.

Other Names for CJC-1295 No DAC

This compound is sold as CJC-1295 No DAC, CJC 1295 without DAC, Modified GRF (1-29), Mod GRF 1-29 and tetrasubstituted GRF (1-29). Its relationship to sermorelin, GRF (1-29) and GHRH (1-44) explains the overlapping names, but only the four-substitution, non-conjugated chain matches what is in this vial.

Related receptor terms include GHRH-R, somatotroph, cAMP and protein kinase A, which describe the pathway it activates in pituitary cells. Some suppliers simply write CJC-1295, which is ambiguous, whereas the words No DAC always appear on our label, so the vial cannot be mistaken for its long-acting sibling.

CJC 1295 DAC vs No DAC, and Pairing With Ipamorelin

Pick by time scale when deciding on CJC 1295 DAC or no DAC. Our CJC-1295 DAC vs No DAC guide covers the chemistry in depth. The No DAC form acts for roughly 30 minutes, preserving the natural pulse pattern and clearing between sampling points. CJC-1295 With DAC, a 5 mg vial at $79, binds albumin and extends activity to several days, suiting designs that need a sustained rise.

Shop ipamorelin as the best peptide to stack with CJC 1295 in ghrelin and GHRH synergy work. Ipamorelin CJC-1295 No DAC studies usually start from separate vials so each amount can be set, while the CJC-1295 No DAC Ipamorelin blend suits a ratio already fixed at equal amounts.